Given miR-146a upregulation is implicated in successful response to anti-IL-6 CSS blockade and that miR-155 upregulation is unique to COVID-19 and not severe influenza, this miRNA regulatory cascade may be a core inflammatory axis in SARS-CoV-2-related disease whose dysregulation is central to its unique disease context. This evidence concerns the gene IL6 and COVID-19.